Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo‐adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution